MARC ayrıntıları
000 -BAŞLIK |
Sabit Uzunluktaki Kontrol Alanı |
04720na a2201009 4500 |
001 - KONTROL NUMARASI |
Control Dosyası |
249061 |
003 - KONTROL NUMARASI KİMLİĞİ |
Kontrol Alanı |
koha_MIRAKIL |
005 - EN SON İŞLEM TARİHİ ve ZAMANI |
Kontrol Alanı |
20221103143648.0 |
008 - SABİT UZUNLUKTAKİ VERİ ÖGELERİ - GENEL BİLGİ |
Sabit Alan |
171013b tu 000 0 |
020 ## - ISBN - ULUSLARARASI STANDART KİTAP NUMARASI |
Isbn |
9781469887562 |
040 ## - KATALOGLAMA KAYNAĞI |
Özgün Kataloglama Kurumu |
CY-NiCIU |
Kataloglama Dili |
tur |
Çeviri Kurumu |
CY-NiCIU |
Açıklama Kuralları |
rda |
041 ## - DİL KODU |
Metin ya da ses kaydının dil kodu |
eng |
082 ## - DEWEY ONU SINIFLAMA SİSTEMİ |
Sınıflama Numarası |
615.1076 |
Cutter numarası |
P43 2015 |
245 ## - ESER ADI BİLDİRİMİ |
Başlık |
Pharmacology: |
Alt Eseradı |
Lippincott's illustrated reviews / |
Sorumluluk Bildirimi |
Edit: Karen Whalen |
250 ## - BASIM BİLDİRİMİ |
Basım Bildirimi |
6th edi. |
260 ## - YAYIN, DAĞITIM, VB. |
Yayın Yeri |
China |
Yayınevi |
Wolters Kluwer |
Yayın Tarihi |
2015 |
264 1# - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
: |
Name of producer, publisher, distributor, manufacturer |
, |
Date of production, publication, distribution, manufacture, or copyright notice |
. |
300 ## - FİZİKSEL TANIMLAMA |
Sayfa, Cilt vb. |
ix, 664 p. |
Diğer fiziki detaylar |
tab., fig. |
Boyutları |
27.5 cm |
336 ## - CONTENT TYPE |
Source |
rdacontent |
Content type term |
text |
Content type code |
txt |
337 ## - MEDIA TYPE |
Source |
rdamedia |
Media type term |
unmediated |
Media type code |
n |
338 ## - CARRIER TYPE |
Source |
rdacarrier |
Carrier type term |
volume |
Carrier type code |
nc |
504 ## - BİBLİYOGRAFİ NOTU |
Bibliyografi Notu |
Includes index ( 641- 664 p.) |
590 ## - Class information |
Local note |
Pharmacology |
590 ## - Class information |
Local note |
PHAR210 -- PHAR307 -- PHAR310 |
650 ## - KONU BAŞLIĞI EK GİRİŞ - KONU TERİMİ |
Konusal terim veya coğrafi ad |
Pharmacology |
650 ## - KONU BAŞLIĞI EK GİRİŞ - KONU TERİMİ |
Konusal terim veya coğrafi ad |
Microbiology |
700 ## - EK GİRİŞ - KİŞİ ADI |
Yazar Adı (Kişi adı) |
Edit: Whalen, Karen |
9 (RLIN) |
4060 |
942 ## - EK GİRİŞ ÖGELERİ (KOHA) |
Sınıflama Kaynağı |
Dewey Onlu Sınıflama Sistemi |
Materyal Türü |
Books |
505 1# - İÇİNDEKİLER NOTU |
Title |
UNIT 1 Principles of Drug Therapy |
505 1# - İÇİNDEKİLER NOTU |
Statement of responsibility |
Venkata Yelolepeddi |
Title |
Pharmacokinetics |
505 1# - İÇİNDEKİLER NOTU |
Statement of responsibility |
Joanna Peris |
Title |
Drug -Receptor Interactions and Pharmacodynamics |
505 1# - İÇİNDEKİLER NOTU |
Title |
UNIT II: Drugs Affecting the Automatic Nervous System |
505 1# - İÇİNDEKİLER NOTU |
Statement of responsibility |
Rajan Radhakrishnan |
Title |
Automatic Nervous System |
505 1# - İÇİNDEKİLER NOTU |
Statement of responsibility |
Rajan Radhakrishnan |
Title |
Cholinergic Agonists |
505 1# - İÇİNDEKİLER NOTU |
Statement of responsibility |
Rajan Radhakrishnan and Thomas B Whalen |
Title |
Cholinergic Antagonists |
505 1# - İÇİNDEKİLER NOTU |
Statement of responsibility |
Rajan Radhakrishnan |
Title |
Adrenergic Agonists |
505 1# - İÇİNDEKİLER NOTU |
Statement of responsibility |
Rajan Radhakrishnan |
Title |
Adrenergic Agonists |
505 1# - İÇİNDEKİLER NOTU |
Title |
UNIT III: Affecting the Central Nervous System |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs for Neurogenerative Diseases |
505 1# - İÇİNDEKİLER NOTU |
Title |
Anxiolytic and Hypnotic Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antidepressants |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antipsychotic Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs for Epilepsy |
505 1# - İÇİNDEKİLER NOTU |
Title |
Anesthetics |
505 1# - İÇİNDEKİLER NOTU |
Title |
Opioids |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs of Abuse |
505 1# - İÇİNDEKİLER NOTU |
Title |
CNS Stimulants |
505 1# - İÇİNDEKİLER NOTU |
Title |
UNIT IV : Drugs Affecting the Cardiovascular System |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antihypertensive |
505 1# - İÇİNDEKİLER NOTU |
Title |
Diuretics |
505 1# - İÇİNDEKİLER NOTU |
Title |
Heart Failure |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antiarrhythmics |
505 1# - İÇİNDEKİLER NOTU |
Title |
Anticoagulants and Antiplatelet Agents |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs For Hyperlipidemia |
505 1# - İÇİNDEKİLER NOTU |
Title |
UNIT V : Drugs Affecting the Endocrine Systems |
505 1# - İÇİNDEKİLER NOTU |
Title |
Pituitary and Thyroid |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs for Diabetes |
505 1# - İÇİNDEKİLER NOTU |
Title |
Estrogen and Androgens |
505 1# - İÇİNDEKİLER NOTU |
Title |
Adrenal Hormones |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs For Obesity |
505 1# - İÇİNDEKİLER NOTU |
Title |
UNITY VI: Drugs For Other Disorder |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs for Disorders of the Respiratory System |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antihistamines |
505 1# - İÇİNDEKİLER NOTU |
Title |
Gastrointestinal and Antiemetic Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs for Urologic Disorders |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs For Anemia |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs For Dermatologic Disorders |
505 1# - İÇİNDEKİLER NOTU |
Title |
Drugs For Bone Disorders |
505 1# - İÇİNDEKİLER NOTU |
Title |
Anti Inflammatory Antipyretic and Analgesic Agents |
505 1# - İÇİNDEKİLER NOTU |
Title |
UNIT VII: Chemotherapeutic Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Principles of Antimicrobial Therapy |
505 1# - İÇİNDEKİLER NOTU |
Title |
Cell Wall Inhibitors |
505 1# - İÇİNDEKİLER NOTU |
Title |
Protein Synthesis Inhibitors |
505 1# - İÇİNDEKİLER NOTU |
Title |
Quinolones Folic Acid Antagonists and Urinary Tract Antiseptics |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antimycobacterial Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antifungal Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antiprotozoal Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Anthelmintic Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Antiviral Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Anticancer Drugs |
505 1# - İÇİNDEKİLER NOTU |
Title |
Immunosuppressants |
505 1# - İÇİNDEKİLER NOTU |
Title |
UNIT VIII: Toxicology |
505 1# - İÇİNDEKİLER NOTU |
Title |
Clinical Toxicology |
505 0# - İÇİNDEKİLER NOTU |
Title |
Index |
505 0# - İÇİNDEKİLER NOTU |
Title |
Figures Sources |
505 1# - İÇİNDEKİLER NOTU |
-- |
1 |
505 1# - İÇİNDEKİLER NOTU |
-- |
25 |
505 1# - İÇİNDEKİLER NOTU |
-- |
39 |
505 1# - İÇİNDEKİLER NOTU |
-- |
51 |
505 1# - İÇİNDEKİLER NOTU |
-- |
65 |
505 1# - İÇİNDEKİLER NOTU |
-- |
77 |
505 1# - İÇİNDEKİLER NOTU |
-- |
95 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jose A Rey |
-- |
107 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jose A Rey |
-- |
121 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jose A Rey |
-- |
135 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jose A Rey |
-- |
147 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jeannine M Conway and Angela K Birnbaum |
-- |
157 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Thomas B Whalen |
-- |
171 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Robin Moorman Li |
-- |
191 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Carol Motyoka and Joseph Spillare |
-- |
205 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jose A Rey |
-- |
215 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Kyle Meiln |
-- |
225 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jason Powell |
-- |
241 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Shawn Anderson and Katherine Vogel Anderson |
-- |
255 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Kristyn Mulqueen |
-- |
281 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Katherine Vogel Anderson and Patrick Cogan |
-- |
291 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Karen Sando |
-- |
311 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Karen Whalen |
-- |
325 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Karen Whalen |
-- |
335 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Karen Whalen |
-- |
351 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Karen Whalen |
-- |
365 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Carol Motyoka |
-- |
375 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Kyle Melin |
-- |
381 |
505 1# - İÇİNDEKİLER NOTU |
-- |
393 |
-- |
Thomas A Panaveil |
505 1# - İÇİNDEKİLER NOTU |
-- |
Carol Motycka |
-- |
401 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Katherine Vogel Anderson |
-- |
415 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Katherine Vogel Anderson and Patrick Cogan |
-- |
423 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Thomas A Panaveill |
-- |
431 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Karen Whalen |
-- |
441 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Eric Dietrich, Nicholas Carris and Thomas A panaveill |
-- |
447 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jamie Kisgen |
-- |
471 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jamie Kisgen |
-- |
483 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Nathan R Unger and Timothy P Gauthier |
-- |
499 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Timothy P Gauthier and Nathan R Unger |
-- |
513 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Charles A Peloquin and Eric Egelund |
-- |
525 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Jamie Kisgen |
-- |
535 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Lisa Clayville Martin |
-- |
547 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Lisa Clayville Martin |
-- |
561 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Elizabeth Sherman |
-- |
567 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Kourtney Laplant and Paige Louzon |
-- |
587 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Sony Tuteja |
-- |
619 |
505 1# - İÇİNDEKİLER NOTU |
-- |
Dawn Sollee |
-- |
631 |
505 0# - İÇİNDEKİLER NOTU |
-- |
641 |
505 0# - İÇİNDEKİLER NOTU |
-- |
663 |